论文部分内容阅读
目的:探讨血清腺苷脱氨酶(Adenosine deaminase,ADA)、总胆汁酸(Total bilious acid,TBA)和α-L-岩藻糖苷酶(α-L-Fucosidase,AFU)联合检测对肝脏疾病的诊断价值。方法:分别测定急性肝炎组、慢性活动性肝炎组、慢性迁延性肝炎组、肝硬化组、肝癌组及健康对照组血清ADA、TBA、AFU、丙氨酸氨基转移酶(ALT)及γ-谷氨酰转移酶(γ-GT)。结果:相对于健康对照组,ADA和TBA在各型肝炎及肝硬化中均有不同程度的升高,而肝癌患者的AFU明显升高,ADA和TBA无明显升高。结论:联合检测血清ADA、TBA和AFU在肝脏疾病的诊断和鉴别诊断中具有更高价值。
Objective: To investigate the effect of serum ADA, TBA and α-L-Fucosidase (AFU) on hepatic diseases Diagnostic value. Methods: The levels of serum ADA, TBA, AFU, ALT and γ-thalassemia in acute hepatitis group, chronic active hepatitis group, chronic persistent hepatitis group, cirrhosis group, liver cancer group and healthy control group were determined respectively Aminotransferase (γ-GT). Results: Compared with healthy controls, ADA and TBA increased in all kinds of hepatitis and cirrhosis to some extent, but AFU in patients with hepatocellular carcinoma was significantly increased and ADA and TBA were not significantly increased. Conclusion: The combined detection of serum ADA, TBA and AFU has higher value in the diagnosis and differential diagnosis of liver diseases.